Investors / United States / Foresite Capital
Foresite Capital
Venture capital · West Hollywood, CA, United States · North America
Foresite Capital is a multi-stage healthcare and life sciences investment firm that funds companies at all stages of their life cycles. It uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare.
Invests inHealthcare & Biotech
In its own wordshealthcarelife sciencesbiotechdata sciencebig datatherapeutics
Your fit with Foresite Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsForesite Capital lists 144 checked portfolio companies on its own site and is named in 17 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 38% of the companies with a known first round. Its largest themes are Healthcare & Biotech (96%), Education (1%) and Fintech (1%). 91% of its companies are based in United States. It invests most often alongside RA Capital, Altamont Pharmaceutical Holdings and Avoro Capital Advisors.
Counts come from funding rounds that name Foresite Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Foresite Capital's whole history. Rounds on record name 16 companies; its own site lists 144. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 38% |
| Series B | 38% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 1 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 2 | 0 |
| '25 | 5 | 0 |
| '26 | 9 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 98th | 144 companies |
| Recent activity | 95th | 10 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 69th | 7% of companies confirmed by a round |
| Sector focus | 97th | 96% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| RA Capital | 22 |
| Altamont Pharmaceutical Holdings | 12 |
| Avoro Capital Advisors | 11 |
| Casdin Capital | 11 |
| Nextech Invest | 10 |
| ARCH Venture Partners | 9 |
| F-Prime Capital | 9 |
| Frazier Life Sciences | 8 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers13090%
- No longer answers00%
- Points to another company1410%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 96% | 15% |
| Education | 1% | 7% |
| Fintech | 1% | 12% |
| Real Estate & Construction | 1% | 3% |
| Media & Entertainment | 1% | 4% |
| AI & Machine Learning | 1% | 18% |
Co-investor network
who it backs companies with, and who they back togetherCompare Foresite Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Foresite Capital| Date | Company | Stage |
|---|---|---|
| 6 Oct 2026 | Series B | |
| 2 Sept 2026 | Series C+ | |
| 13 Aug 2026 | Series B | |
| 9 Jun 2026 | Series C+ | |
| 26 Mar 2026 | Series B Led | |
| 24 Feb 2026 | Series A | |
| 18 Feb 2026 | Series A | |
| 8 Jan 2026 | Series C+ |
Round details for Foresite Capital
Amounts, full round histories and every co-investor in Foresite Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
144 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
Healthcare & Biotech | Portfolio page | |||
Healthcare & Biotech | Portfolio page | |||
| Aclaris Therapeutics is a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions. | Healthcare & Biotech | Portfolio page | ||
| Adaptimmune is involved in cell therapies against cancer. | Healthcare & Biotech | Portfolio page | ||
| Adicet Bio develops gamma delta T cell therapies for patients with autoimmune diseases and cancer. | Healthcare & Biotech | Portfolio page | ||
| Aduro provides corporate wellness solutions and health benefits strategies for employers and employees | Healthcare & Biotech | Portfolio page | ||
| Aeovian Pharmaceuticals develops small molecules to treat certain rare genetic and age-related diseases | Healthcare & Biotech | Dec 2025Series B | Funding round | |
| Datavant securely connects, protects, and activates health data across the healthcare ecosystem through a data collaboration platform | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Akero Therapeutics is pioneering novel therapies to transform the lives of people living with serious metabolic diseases | Healthcare & Biotech | Portfolio page | ||
| Alector develops therapies for neurodegenerative diseases | Healthcare & Biotech | Portfolio page | ||
| Allogene Therapeutics develops cell therapies, including CAR T treatments, for cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Alumis Inc is focused on immune-mediated disease therapies | Healthcare & Biotech | Portfolio page | ||
| ALX Oncology is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives. | Healthcare & Biotech | Portfolio page | ||
| Ambit Biosciences Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. | Healthcare & Biotech | Portfolio page | ||
| The company is a virology-focused biotech that brings its portfolio of clinical assets to patients with unmet medical needs, particularly in the area of hepatitis B virus (HBV). | Healthcare & Biotech | Portfolio page | ||
| Arcus Biosciences creates medicines by advancing validated biology with exceptional chemistry. | Healthcare & Biotech | Portfolio page | ||
| Ardelyx delivers first-in-class medicines to patients with unmet medical needs. | Healthcare & Biotech | Portfolio page | ||
| The company is dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers. | Healthcare & Biotech | Portfolio page |
About this data
site last read 11 Nov 2026- Site
- foresitecapital.com
- Last read
- 11 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 26 May 2020
- Companies checked
- 144
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Foresite Capital's profile as data
Pull Foresite Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/foresitecapital.com
# also
GET /v1/firms/foresitecapital.com/portfolio
GET /v1/firms/foresitecapital.com/coinvestors
GET /v1/firms/foresitecapital.com/news